The use of psychotropic medications in young children: The facts, the controversy, and the practice

Connecticut Medicine

Volumn 64, Issue 6, 2000, Pages 329-333

  Stubbe, Dorothy E ^b   Martin, Andres ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMPHETAMINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CENTRAL STIMULANT AGENT; CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; CLONIDINE; DEXAMPHETAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; GUANFACINE; HALOPERIDOL; IMIPRAMINE; METHYLPHENIDATE; NEFAZODONE; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PEMOLINE; PEMOLINE MAGNESIUM; PIMOZIDE; PSYCHOTROPIC AGENT; SERTRALINE; THIORIDAZINE; UNINDEXED DRUG; VENLAFAXINE;

CHILD CARE; CHILD PSYCHIATRY; CLINICAL PRACTICE; DRUG USE; HUMAN; LAW; PEDIATRICS; PRESCRIPTION; REVIEW;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; CONNECTICUT; DECISION MAKING; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTROPIC DRUGS;

EID: 0033938969     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Emslie GJ, Walkup JT, Pliszka SR, Ernst M: Nontricyclic antidepressants: Current trends in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999; 38:517-28.
2. Minde K: The use of psychotropic medication in preschoolers: Some recent developments. Can J Psychiatry 1998; 43:571-5.
3. Pincus HA, Tanielian TL, Marcus SC, et al: Prescribing trends in psychotropic medications: Primary care, psychiatry, and other medical specialties. JAMA 1998; 279:526-31.
4. Safer DJ, Zito JM, Fine EM: Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 1996; 98: 1084-8.
5. Zito JM, Safer DJ, dosReis S, et al: Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000; 283: 1025-30.
6. Jensen PS, Bhatara VS, Vitiello B, et al: Psychoactive medication prescribing practices for U.S. children: Gaps between research and clinical practice. J Am Acad Child Adolesc Psychiatry 1999; 38:557-65.
7. Vitiello B, Jensen PS: Medication development and testing in children and adolescents. Current problems, future directions. Arch Gen Psychiatry 1997; 54:871-6.
8. American Academy of Pediatrics Committee on Drugs: Unapproved uses of approved drugs: The physician, the package insert, and the Food and Drug Administration. Pediatrics 1996; 98:143-5.
9. Institute of Medicine: Research on children and adolescents with mental, behavioral and developmental disorders, Washington DC: National Academy Press; 1989.
10. McDougle CJ, Scahill L, McCracken JT, et al: Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. Child Adolesc Psychiatr Clin N Am 2000; 9(1):201-24.
11. Riddle MA, Labellarte MJ, Walkup JT: Pediatric psychopharmacology: Problems and prospects. J Child Adolesc Psychopharmacol 1998; 8:87-97.
12. Greenhill LL: The use of psychotropic medication in preschoolers: Indications, safety, and efficacy. Can J Psychiatry 1998; 43: 576-81.
13. Alessandri SM, Schramm K: Effects of dextroamphetamine on the cognitive and social play of a preschooler with ADHD. J Am Acad Child Adolesc Psychiatry 1991; 30:768-72.
14. Barkley RA: The effects of methylphenidate on the interactions of preschool ADHD children with their mothers. J Am Acad Child Adolesc Psychiatry 1988; 27:336-41.
15. Firestone P, Musten LM, Pisterman S, et al: Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: A double-blind placebo-controlled study. J Child Adolesc Psychopharmacol 1998; 8: 13-25.
16. Mayes SD, Crites DL, Bixler EO, et al: Methylphenidate and ADHD: Influence of age, IQ and neurodevelopmental status. Dev Med Child Neurol 1994; 36:1099-107.
17. Schleifer M, Weiss G, Cohen N, Elman M, Cvejic H, Kruger E: Hyperactivity in preschoolers and the effect of methylphenidate. Am J Orthopsychiatry 1975; 45(1):38-50.
18. Spencer T, Biederman J, Wilens T, et al: Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996; 35:409-32.
19. Conners KC: Controlled trial of methylphenidate in preschool children with minimal brain dysfunction. Int J Ment Health 1975; 4:61-74.
20. Physician's Desk Reference (PDR), 54th Edition. Montvale, NJ: Medical Economics Company; 2000.
21. American Academy of Child and Adolescent Psychiatry: Practice parameters for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997; 36(10 Suppl):85S-121S.
22. Schachar R, Tannock R: Childhood hyperactivity and psychostimulants: A review of extended treatment studies. J Child Adolesc Psychopharmacol 1993; 3:81-97.
23. Vitiello B: Pediatric psychopharmacology and the interaction between drugs and the developing brain. Can J Psychiatry 1998; 43:582-4.
24. Harmon RJ, Riggs PD: Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry 1996; 35:1247-9.
25. Lee BJ: Clinical experience with guanfacine in 2- and 3-year-old children with attention deficit disorder. Infant Ment Health J 1997; 18:300-305.
26. Davilla RR, Williams ML, MacDonald JT: Clarification of policy to address the needs of children with attention deficit hyperactivity disorders with general and/or special education. Washington, D.C.: U.S. Department of Education, Office of Special Education 1991: Memorandum of September 16.
27. National Institute of Mental Health: Treatment of Young Children with Mental Conditions: White House Conference fact sheet, http:/ /www.nimh.nih.gov/publicat/whmedchild.cfm 2000:March 20.
28. American Academy of Child and Adolescent Psychiatry: Practice parameters for the psychiatric assessment of children and adolescents. J Am Acad Child Adolesc Psychiatry 1995; 34: 1386-1402.
29. Arnold LE, Abikoff HB, Cantwell DP, et al: National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry 1997; 54:865-70.
30. MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999; 56:1073-86.